ESC 365 - Hysteresis between pharmacokinetics and changes in QRS complex duration following flecainide administered via oral inhalation or IV infusion

ESC Premium Access

Hysteresis between pharmacokinetics and changes in QRS complex duration following flecainide administered via oral inhalation or IV infusion

Session: Poster Session 4 - Arrhythmia and cardio protection pharmacotherapy

Topic: Antiarrhythmic Pharmacotherapy

Speaker: Ms P. Madhavapeddi (Newark, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Ms Prashanti Madhavapeddi

InCarda Therapeutics, Newark (United States of America)

0 follower

5 more presentations in this session

Proarrhythmic pharmacotherapy and out-of-hospital cardiac arrest - A nationwide Danish study

Speaker: Mr S. Kjeldsen (Gentofte, DK)

Ivabradine is not associated with higher risk of new onset atrial fibrillation among patients with cardiac resynchronization therapy

Speaker: Doctor J. Milner (Coimbra, PT)

SK channel inhibition did not increase short-term variability of the QT intervals in atrial tachypaced pigs with left ventricular dysfunction in contrast to the positive control dofetilide

Speaker: Miss C. Citerni (Copenhagen, DK)

AMPK/PGC1 activation by melatonin attenuates acute doxorubicin cardiotoxicity

Speaker: Doctor D. Liu (Beijing, CN)

Beneficial effect of landiolol on adiponectin and high-molecular weight adiponectin level in patients with stable coronary artery disease performed percutaneous coronary intervention

Speaker: Assistant Professor M. Kiyokuni (Yokohama, JP)

Access the full session

Poster Session 4 - Arrhythmia and cardio protection pharmacotherapy

Speakers: Ms P. Madhavapeddi, Mr S. Kjeldsen, Doctor J. Milner, Miss C. Citerni, Doctor D. Liu...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources